Interactive POWER Rehabilitation System on Rehabilitation Training for Patients With Parkinson's Disease
Developing Visual Feedback-aided Power Rehabilitation System and Exploring Its' Applications on Rehabilitation Training for Patients With Parkinson's Disease
調査の概要
詳細な説明
Parkinson's disease (PD) is a progressive neurodegenerative disease of the central nervous system with complex etiology. This disease is related to the consumption of dopamine in the substantia nigra of the brain, and it is currently believed that the main factors of consumption of dopamine are (1) heredity (2) aging (3) environment.
At present, there are many rehabilitation treatments available for patients with Parkinson's disease, such as: progressive resistance training, yoga, Tai Chi, dancing, cognitive training, balance training, gait training, bicycle, and treadmill training, etc. During the recent years, the POWER rehabilitation system from Japan (Procedure Outcome Worthwhile for Elderly Rehabilitation, referred to as POWER rehabilitation) including six types of equipment for strengthening different body parts has been applied to frail elderly or neurological patients gradually.
Parkinson's patients are often considered to have major difficulties in responding to motion disturbances (inability to respond appropriately), leading to learning, insufficient attention and motivation problems. Therefore, maintenance of motivation and feedback on performance are key factors that affect the participation of exercises in patients with Parkinson's disease.
The application of virtual reality in patients with PD is becoming more and more effective. An integrated rehabilitation system can not only enable the clinicians to check the rehabilitation status during the treatment, but also provide feedbacks to the patient through the interactive visual feedback screen. For Parkinson's patients, providing visual feedback through virtual reality intervention may be of particular clinical value.
In the first phase of this study, a virtual reality-like visual feedback system will be developed and combined with the original "POWER rehabilitation system" to form the so-called "Interactive POWER Rehabilitation System", and then system verification will be carried out. In the second phase of this study, this newly developed system will be applied to the rehabilitation training for patients with Parkinson's disease, and to explore whether the combination of POWER rehabilitation with visual feedback can produce the clinical benefits, as well as improving the daily life of patients with PD. Patients will be randomly assigned into three groups: interactive POWER, functional training, and control group. Single blind data collection will be used. Patients will be evaluated at baseline and post 12-week interventions. Outcome measures will include mini-BESTest, Unified Parkinson's disease rating scale, muscle strength of upper and lower extremities, timed up and go, 6-minute walking test, gait, and Parkinson's disease questionnaire PDQ-39.
It is expected that the "Interactive POWER Rehabilitation System" can promote the learning ability of patients with Parkinson's disease by adding visual feedbacks and enhance the treatment effects. It also offer rehabilitation clinicians more treatment options, lower the administrative costs of supporting staffs, reduce commuting costs for the patients, and elevate patients' desire to comply with the treatment program.
研究の種類
入学 (予想される)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Szu-Min Fu, Student
- 電話番号：886-982202892
- メール：szuminfu.be09@nycu.edu.tw
研究連絡先のバックアップ
- 名前：Wei-Di Chen, Student
- 電話番号：886-966070329
- メール：wdcdino0329.be09@nycu.edu.tw
研究場所
-
-
-
New Taipei City、台湾、220
- 募集
- Far Eastern Memorial Hospital
-
コンタクト：
- Chao-Chun Huang, Bachelor
- 電話番号：866-2-77281501
-
New Taipei City、台湾
- 募集
- Taipei Veterans General Hospital
-
コンタクト：
- Si-Huei Lee, PhD
- 電話番号：886-938591985
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria of phase I study
- Healthy Volunteer (can walk 15 meters independently or with assistive devices).
- Aged 20-70 years old.
- Mini-mental state examination (MMSE) points above 24.
- Not familiar with POWER rehabilitation machines before this study.
- Able to understand POWER rehabilitation training and test items.
- Able to use smart devices and be willing to cooperate with pre-acceptance instructions.
- Able to communicate in Mandarin or Taiwanese, and be able to clearly express uncomfortable feelings.
- Willing to participate in this study after explanations, and sign the subject's informed consent.
Inclusion Criteria of phase II study
- Diagnosed as Idiopathic Parkinsonism by Neurologist
- PD stages of I-III according to the modified Hoehn and Yahr Scale
- Aged 45-85 years old
- Mini-mental state testing (MMSE) 24 points or more
- Stable medication regimen for at least 2 weeks before the trial
- Can walk 15 meters independently or with devices
- Able to understand treatment and assessment
- Able to understand and be willing to agree to the informed consent form
Exclusion Criteria of phase I study
- People who do not use smart devices and are unwilling to cooperate with the pre-acceptance instructions.
- Have severe hearing or vision impairments.
- Pregnant or breast-feeding.
- Any chronic condition that may cause safety concerns.
- Having any diseases which are contraindications for exercise participation.
- Muscle strength is affected by taking drugs.
- Have been to the gym 6 months before participating in the study (e.g. aerobic exercise, resistance training).
- Severe orthopedic diseases (unhealed fractures, severe joint destructions, and joints with fixed deformities, etc.).
- Severe or unstable neurological or cardiopulmonary diseases (severe cases of stroke and myocardial infarction in the acute phase, arrhythmia or uncontrolled blood pressure, etc.).
- Diagnosed with any mental illness (e.g., depression, psychosis or other mental illnesses)
- Unwilling to participate in this research.
Exclusion Criteria of phase II study
- Rheumatism
- Cardiovascular diseases or respiratory diseases (e.g., angina pectoris, pulmonary embolism, etc.)
- Severe or unstable neurological or orthopedic diseases.
- Severe hearing or vision impairments
- Diagnosed with any mental illness(e.g., depression, psychosis or other mental illnesses)
- A history of epilepsy.
- Pregnancy or pregnancy
- Any uncontrolled disease.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし：対照群
普段のお手入れ
|
|
|
実験的：Interactive POWER rehabilitation
Participants in this group would be treated with POWER for twice a week, total 12 weeks.
|
Interactive POWER rehabilitation training for twice a week, total 12 weeks, that consisted of 6 types of equipment for strength training.
|
|
アクティブコンパレータ：Conventical physical training Group
Participants in this group would be treated with traditional exercise rehabilitation for twice a week, total 12 weeks.
|
Conventional physical training models in current clinical use for twice a week, total 12 weeks, that consisted of strength training, balance training, stretching, gait training, and etc.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change from Baseline Unified Parkinson's Disease Rating Scale at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
A comprehensive assessment of both motor and non-motor symptoms associated with Parkinson's.
The Unified Parkinson's Disease Rating Scale is made up of 42 items.
These items are divided into six sections which are separately "evaluation of mentation, behavior, and mood", "self-evaluation of the activities of daily life", "clinician-scored monitored motor evaluation", "complications of therapy", "Hoehn and Yahr staging of severity of Parkinson's disease" and "Schwab and England ADL scale".The evaluation score for the first item to the 39th item is 0 to 4 points.
The evaluation score for the 40th to the 42th item is 0 to 1 points.
The higher score meand the worse condition.
The sum of all the items'score is the score of the scale.
Higher Rating Scales'scores indicate severe symptoms.
|
Baseline and post-intervention at 12 weeks
|
|
Change from Baseline he Parkinson's Disease Questionnaire (PDQ-39) at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
The 39-point PDQ provides scores for each of the 8 scales: mobility, activities of daily living, emotional well-being, stigma, social support, cognitions, communications and bodily discomfort.
It is used to assess the overall health-related quality of life profile of the individual questioned.
|
Baseline and post-intervention at 12 weeks
|
|
Change from Baseline the Mini-Mental State Exam (MMSE) at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
A widely used test of cognitive function among the elderly; it includes tests of orientation, attention, memory, language and visual-spatial skills.
The score of 24 or more (out of 30) indicates a normal cognition.
Below this, scores can indicate severe (≤9 points), moderate (10-18 points) or mild (19-23 points) cognitive impairment.
The raw score may also need to be corrected for educational attainment and age.
|
Baseline and post-intervention at 12 weeks
|
|
Change from Baseline the Timed Up and Go test (TUG) at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
A simple test used to assess a person's mobility and requires both static and dynamic balance. It measures the time that a person takes to rise from a chair, walk three meters, turn around 180 degrees, walk back to the chair, and sit down while turning 180 degrees. |
Baseline and post-intervention at 12 weeks
|
|
Change from Baseline Mini-BESTest at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
The scale includes four items: (1) anticipatory balance, (2) reactive posture control, (3) sensory orientation, and (4) dynamic gait, A total of 14 measurement items, 2 points for each question, a total of 28 points.
|
Baseline and post-intervention at 12 weeks
|
|
Change from Baseline six minute walk test (6MWT) at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
Walk for six minutes at the subject's preferred speed and assistive devices.
You can stop at any time in the middle.
After the end, the walking distance will be recorded, and changes in heartbeat, blood pressure, blood oxygen saturation, dyspnea and fatigue will be monitored.
It will also end at the end then evaluate the walking distance.
|
Baseline and post-intervention at 12 weeks
|
|
Change from Baseline muscle strength of upper limbs at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
Use a hand-grip dynamometer to test the grip strength.
Both hands need to be measured twice individually, with a rest time of at least 30 seconds between the two.
|
Baseline and post-intervention at 12 weeks
|
|
Change from Baseline muscle strength of lower limbs at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
Use Micro FET3 instrument to measure knee joint extension and flexion; hip joint abduction and flexion muscle strength.
Each muscle group needs to be tested twice, with a 30-second rest between the two, and two recordings Take the maximum value afterwards.
|
Baseline and post-intervention at 12 weeks
|
|
Change from Baseline gait Speed at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
The subjects were asked to wear an inertial sensor "Physilog®" (Gait Up, Lausanne, Switzerland) on each foot during a 10-meter walking test to collect gait data. Spatiotemporal gait parameters were calculated with the Gait Analysis Software provided by Gait Up, including the following lists. Stopwatch will also be employed by the operator to measure the walking time simultaneously. - Speed (m/s): Mean walking stride velocity of forward walking |
Baseline and post-intervention at 12 weeks
|
|
Change from Baseline cadence at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
The subjects were asked to wear an inertial sensor "Physilog®" (Gait Up, Lausanne, Switzerland) on each foot during a 10-meter walking test to collect gait data. Spatiotemporal gait parameters were calculated with the Gait Analysis Software provided by Gait Up. - Cadence (step/minute): Number of steps in a minute |
Baseline and post-intervention at 12 weeks
|
|
Change from Baseline stride length at 12 weeks
時間枠：Baseline and post-intervention at 12 weeks
|
The subjects were asked to wear an inertial sensor "Physilog®" (Gait Up, Lausanne, Switzerland) on each foot during a 10-meter walking test to collect gait data. Spatiotemporal gait parameters were calculated with the Gait Analysis Software provided by Gait Up. - Stride length (m): Distance between two consecutive footprints on the ground |
Baseline and post-intervention at 12 weeks
|
協力者と研究者
捜査官
- スタディチェア：Si-Huei Lee, PhD、Taipei Veterans General Hospital, Taiwan
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- 2021-05-004A
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
パーキンソン病の臨床試験
-
Adelphi Values LLCBlueprint Medicines Corporation完了肥満細胞性白血病 (MCL) | 攻撃的な全身性肥満細胞症 (ASM) | SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD) | くすぶり全身性肥満細胞症 (SSM) | 無痛性全身性肥満細胞症 (ISM) ISM サブグループが完全に募集されましたアメリカ
Interactive POWER rehabilitationの臨床試験
-
Tulane UniversityNational Institute of Mental Health (NIMH)積極的、募集していない
-
Duke-NUS Graduate Medical SchoolSingapore General Hospital; Changi General Hospital; National Medical Research Council (NMRC),... と他の協力者完了
-
Centre Hospitalier Universitaire de Saint EtienneAssociation pour le Développement de la Recherche sur l'Appareil Locomoteur dans la Loire完了
-
Taipei Veterans General Hospital, Taiwanわからない
-
Universiti Sultan Zainal Abidin募集
-
University of North Carolina, Chapel HillCenters for Disease Control and Prevention完了